New shot aims to halt ovaries in breast cancer fight

NCT ID NCT07310420

First seen Jan 03, 2026 · Last updated May 21, 2026 · Updated 22 times

Summary

This study tests a single shot of ZOLADEX 10.8 mg to temporarily stop ovarian function in premenopausal women with advanced hormone-positive breast cancer. The goal is to see if the shot can lower certain hormones and stop periods. About 88 women aged 18 to 55 will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cancer Centers of Florida

    RECRUITING

    Ocoee, Florida, 34761, United States

    Contact

  • Duly Health and Care

    RECRUITING

    Lisle, Illinois, 60532, United States

    Contact

  • Genesis Cancer and Blood Institute

    RECRUITING

    Hot Springs, Arkansas, 71913, United States

    Contact

  • Guthrie Medical Group

    RECRUITING

    Sayre, Pennsylvania, 18840, United States

    Contact

  • Oncology Consultants PA

    RECRUITING

    Houston, Texas, 77030, United States

  • Orchard Healthcare Research

    RECRUITING

    Skokie, Illinois, 60077, United States

    Contact

  • Profound Research LLC at Michigan Hematology and Oncology Consultants

    RECRUITING

    Royal Oak, Michigan, 48073, United States

    Contact

  • San Juan Oncology Associates

    RECRUITING

    Farmington, New Mexico, 87401, United States

    Contact

  • Summit Cancer Care

    RECRUITING

    Savannah, Georgia, 31405, United States

    Contact

  • The Mark H. Zangmeister Center-Mid Ohio Oncology/Hematology, Inc.

    RECRUITING

    Columbus, Ohio, 43219, United States

    Contact

Conditions

Explore the condition pages connected to this study.